IL‐17 production by γδ T cells is important for the antitumor effect of Mycobacterium bovis bacillus Calmette‐Guérin treatment against bladder cancer
Authors:
Open Access
- 8 December 2010
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 41 (1) , 246-251
Abstract
Intravesical inoculation of Mycobacterium bovis bacillus Calmette‐Guérin (BCG) has been used for the treatment of bladder cancer. Recent studies implied the requirement of neutrophil infiltration for the antitumor effect. In this study, we found that IL‐17 was produced in the bladder after BCG treatment, preceding the infiltration of neutrophils. Neutrophils in the bladder after BCG treatment were reduced in IL‐17‐deficient mice, in which BCG‐induced antitumor effect against intravesically inoculated bladder cancer was abolished. Notably, the level of IL‐17 production and the number of neutrophils in BCG‐treated bladder was reduced in γδ T‐cell‐deficient mice but not in CD4‐depleted mice. Survival of bladder cancer‐inoculated γδ T‐cell‐deficient mice was not improved by BCG treatment. These results suggest that IL‐17‐producing γδ T cells play a key role in the BCG‐induced recruitment of neutrophils to the bladder, which is essential for the antitumor activity against bladder cancer.Keywords
This publication has 21 references indexed in Scilit:
- Interleukin-1 and IL-23 Induce Innate IL-17 Production from γδ T Cells, Amplifying Th17 Responses and AutoimmunityImmunity, 2009
- Endogenous IL-17 contributes to reduced tumor growth and metastasisBlood, 2009
- IL-17 and Th17 CellsAnnual Review of Immunology, 2009
- Tumor-specific Th17-polarized cells eradicate large established melanomaBlood, 2008
- Neutrophil Granulocytes Are Required for EffectiveBacillus Calmette-GuérinImmunotherapy of Bladder Cancer and Orchestrate Local Immune ResponsesCancer Research, 2006
- Neutrophil stimulation with Mycobacterium bovis bacillus Calmette-Guérin (BCG) results in the release of functional soluble TRAIL/Apo-2LBlood, 2005
- Interleukin-17 enhances bFGF-, HGF- and VEGF-induced growth of vascular endothelial cellsImmunology Letters, 2005
- Interleukin-17 Family Members and InflammationImmunity, 2004
- Tumor Necrosis Factor-Related Apoptosis-Inducing LigandCancer Research, 2004
- Interleukin-17 promotes angiogenesis and tumor growthBlood, 2002